Acute ischemic stroke
Conditions
Interventions
Enhanced intervention group:Receive individualized temperature health risk warning and prevention risk factor management information for stroke through the App
Temperature health risk early warning group:Receive individualized temperature health risk warning through the App
Risk factor management group:Receive individualized prevention risk factor management information for stroke through the App
Routine education group:Only receive routine health education, without receiving individualized temperature health risk warning or prevention risk factor management information for stroke through the
Sponsors
Xuanwu Hospital Capital Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1 Aged 40 to 80, with no gender restrictions; 2 Acute ischemic stroke inpatients within 2 weeks of onset, where the onset time is the time when stroke symptoms appear or the last known normal time of the patient (when it is an onset during sleep or the symptom onset time cannot be accurately obtained due to aphasia, impaired consciousness, etc.); 3 Confirmed diagnosis of ischemic stroke by CT or MRI of the brain within 2 weeks after symptom onset; 4 Local residents (residing for >= 6 months); 5 Patients who voluntarily participate in the study, have high compliance, and can sign the informed consent form; 6 Patients who own a smartphone or other smart devices. Only patients who meet all of the above criteria can be included in the study.
Exclusion criteria
Exclusion criteria: 1 Patients diagnosed with other cerebrovascular diseases (hemorrhagic stroke, transient ischemic attack, cerebral venous sinus thrombosis, etc.) or non-cerebrovascular diseases; 2 Known pregnant or lactating women, or those who tested positive on a pregnancy test before cluster randomization; 3 Patients with other conditions that may affect participation in the trial (e.g., refractory hypertension, severe aphasia, etc.); 4 Patients undergoing psychiatric/psychological treatment that may contaminate the results; 5 Patients with a life expectancy of less than one year (e.g., coexisting malignant tumors, severe cardiopulmonary diseases, etc.); 6 Patients already participating in other interventional clinical studies that may influence the outcome assessment; 7 Patients for whom the investigator deems unsuitable for participation in this study or who may pose significant risks to the patients (e.g., cognitive impairment preventing understanding and/or compliance with the study procedures and/or follow-up). If any of the above exclusion criteria are met, the patient will not be included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year recurrence rate of stroke; | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-month, 6-month, 9-month recurrence rate of stroke;Incidence of adverse cerebrovascular events;Functional index change;Effects on biomarkers;Improved Rankin scale and European five-dimensional five-level Health Scale score;Environmental risk perception or stroke health literacy score;Risk perception of stroke recurrence;Compliance; | — |
Countries
China
Contacts
Public ContactHao Junwei
Xuanwu Hospital Capital Medical University
Outcome results
None listed